Follow
Metabolic imaging
Metabolic imaging observes changes in metabolic pathways to help detect medical conditions. In addition to diagnosis, metabolic imaging can be used to evaluate therapeutic response to assist in treatment management. Metabolic imaging can be done with a variety of non-invasive techniques including positron emission tomography (PET) scans and magnetic resonance imaging (MRI).
FEB 27, 2019 | 1:30 PM
Cellular research is optimal when using physiologically-relevant cell phenotypes and genotypes of human origin. This assertion has accelerated the adoption of primary cells, stem cells, and i...
NOV 15, 2018 | 10:30 AM
The main problem for insufficient cervical cancer screening globally (less than 20% women at risk) is outreach failure. Enabling POCs with modern IT/mobile technology and connecting them with...
NOV 15, 2018 | 8:00 AM
DATE: November 15, 2018TIME: 11:00am EST, 5:00pm CET Applications of micro-CT technology in endodontics Abstract ...
NOV 15, 2018 | 4:00 AM
Development of physiologically relevant cellular models, with strong translatability to human pathophysiology, is critical for identification and validation of novel therapeutic targets. Cell...
NOV 15, 2018 | 1:00 AM
DATE: November 15, 2018TIME: 10:00am CET, 5:00pm CST Applications of micro-CT technology in endodontics Abstract Microcomputed tomography (mic...
NOV 01, 2018 | 12:00 AM
During this webcast Dr. Mayumi Fujita of the National Institutes for Quantum and Radiological Science and Technology in Japan will address the method of real-time imaging of invading cells us...
OCT 11, 2018 | 1:30 PM
As the most common female malignancy, breast cancer is the most likely reason that a woman will die of cancer around the world. Breast cancer mortality has dropped in the U.S. by 35% since 19...
OCT 11, 2018 | 12:00 PM
Lung cancer is the leading cause of cancer-related mortality worldwide. Large-scale sequencing studies have revealed the complex genomic landscape of NSCLC and genomic differences between lun...
OCT 11, 2018 | 10:30 AM
Antibodies are extremely valuable and ubiquitous tools in life science research, but in spite of their widespread use in immunoassays over the past several decades, there is still a lack of u...
OCT 11, 2018 | 10:30 AM
Two projects looking at novel approaches to targeting inflammatory breast cancer will be presented. Inflammatory breast cancer (IBC) is a unique, understudied, and most lethal subtype account...
OCT 11, 2018 | 9:00 AM
The oncogenic transcription factor c-MYC (MYC) is deregulated, and often overexpressed, in more than 50% of cancers. MYC deregulation is associated with poor prognosis and aggressive disease,...
